Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists

被引:16
作者
Kantak, KM [1 ]
Edwards, MA [1 ]
O'Connor, TP [1 ]
机构
[1] Boston Univ, Dept Psychol, Behav Neurosci Lab, Boston, MA 02215 USA
关键词
CGP; 37849; cocaine; dizocilpine; drug discrimination; magnesium chloride; MK-801; NMDA antagonists; NPC; 17742; phencyclidine; schedule-controlled behavior;
D O I
10.1016/S0091-3057(97)00379-1
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The purpose of this study was to determine the extent to which N-methyl-D-aspartic acid (NMDA) antagonists modified the discriminative stimulus effects of cocaine in rats trained to discriminate 5 mg/kg cocaine from vehicle on a fixed-ratio schedule of food presentation as well as the rate-altering effects of cocaine in rats maintained on a fixed-interval schedule of food presentation. NMDA-associated ion channel blockers (dizocilpine, phencyclidine, and magnesium chloride) and competitive NMDA antagonists (NPC 17742 and CGP 37849) displayed similar behavioral effects when administered alone: each drug engendered intermediate levels of cocaine-appropriate responses and rate-dependent effects on food-reinforced operant responding. Selected doses of dizocilpine, magnesium chloride, and phencyclidine given in combination with 1 mg/kg cocaine produced more cocaine-appropriate responses than this dose of cocaine alone. In addition, dizocilpine and magnesium chloride each attenuated the discriminative stimulus effects of higher doses of cocaine. The competitive NMDA antagonists did not appreciably modify the discriminative stimulus effects of any dose of cocaine. Under the fixed-interval schedule, each NMDA antagonist attenuated the effects of 3 mg/kg cocaine, which normally produced maximal increases in response rate. Attenuation of the rate-decreasing effects of the highest dose of cocaine (30 mg/kg) also were observed after pretreatment with dizocilpine and magnesium chloride. These findings demonstrated differences in the way that NMDA-associated ion channel blockers and competitive NMDA antagonists interact with cocaine, and suggest that some NMDA-associated ion channel blockers may either enhance or antagonize the effects of cocaine, depending on the dose and type of behavioral procedure. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 71 条
[1]   EFFECTS OF SEVERAL CATIONS ON THE NEURONAL UPTAKE OF DOPAMINE AND THE SPECIFIC BINDING OF [H-3] GBR 12783 - ATTEMPTS TO CHARACTERIZE THE NA+ DEPENDENCE OF THE NEURONAL TRANSPORT OF DOPAMINE [J].
AMEJDKICHAB, N ;
BENMANSOUR, S ;
COSTENTIN, J ;
BONNET, JJ .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (05) :1795-1804
[2]  
BALSTER RL, 1978, NIDA RES MONOGR, V21, P53
[3]  
BERGMAN J, 1995, J PHARMACOL EXP THER, V273, P40
[4]  
BERGMAN J, 1991, J PHARMACOL EXP THER, V258, P910
[5]  
BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150
[6]   THE GLYCINE NMDA RECEPTOR ANTAGONIST, R-(+)-HA-966, BLOCKS ACTIVATION OF THE MESOLIMBIC DOPAMINERGIC SYSTEM INDUCED BY PHENCYCLIDINE AND DIZOCILPINE (MK-801) IN RODENTS [J].
BRISTOW, LJ ;
HUTSON, PH ;
THORN, L ;
TRICKLEBANK, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) :1156-1163
[7]   EFFECTS OF DOPAMINERGIC AND GLUTAMATERGIC RECEPTOR ANTAGONISTS ON THE ACQUISITION AND EXPRESSION OF COCAINE CONDITIONING PLACE PREFERENCE [J].
CERVO, L ;
SAMANIN, R .
BRAIN RESEARCH, 1995, 673 (02) :242-250
[8]   EFFECTS OF THE DOPAMINE AUTORECEPTOR ANTAGONIST (-)-DS121 ON THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-AMPHETAMINE AND COCAINE [J].
CLARK, D ;
EXNER, M ;
FURMIDGE, LJ ;
SVENSSON, K ;
SONESSON, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 275 (01) :67-74
[9]   CENTRAL SYMPATHOMIMETIC ACTIVITY OF (+)-5-METHYL-10,11-DIHYDRO-5H-DIBENZO [A,D]CYCLOHEPTEN-5, 10-IMINE (MK-801), A SUBSTANCE WITH POTENT ANTICONVULSANT, CENTRAL SYMPATHOMIMETIC, AND APPARENT ANXIOLYTIC PROPERTIES [J].
CLINESCHMIDT, BV ;
MARTIN, GE ;
BUNTING, PR ;
PAPP, NL .
DRUG DEVELOPMENT RESEARCH, 1982, 2 (02) :135-145
[10]  
COLPAERT FC, 1984, J PHARMACOL EXP THER, V230, P193